ResMed RMD Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Residential Care Software | $670.9M+1.5% | $661.18M+1.6% | $650.8M+1.5% | $641.44M+2.4% | $626.37M+2.2% | |
| Sleep and Breathing Health | $4.87B+2.7% | $4.74B+2.8% | $4.61B+2.3% | $4.5B+2.5% | $4.4B+1.9% | |
| Operating Income (Loss) by Business | ||||||
| Residential Care Software | $217.63M+2.4% | $212.56M+0.6% | $211.4M+3.1% | $205M+6.6% | $192.29M+8.1% | |
| Sleep And Breathing Health | $2.2B+3.8% | $2.12B+4.1% | $2.03B+3.5% | $1.96B+4.2% | $1.89B+2.1% | |
| Selling, general, and administrative by Business | ||||||
| Residential Care Software | $149.87M+0.6% | $149.04M+4.1% | $143.22M-0.2% | $143.52M+1.7% | $141.08M-0.9% | |
| Sleep And Breathing Health | $573.77M+5.1% | $545.82M+5.6% | $516.91M+5.2% | $491.59M+6.3% | $462.64M+1.9% | |
| Cost of Sales by Business | ||||||
| Residential Care Software | $201.68M+1.3% | $199.17M+0.9% | $197.48M+1.3% | $194.96M+0.5% | $193.99M+0.4% | |
| Sleep And Breathing Health | $1.88B+0.7% | $1.87B+0.8% | $1.86B+0.2% | $1.85B+1.2% | $1.83B+1.2% | |
| Depreciation and amortization by segment by Business | ||||||
| Residential Care Software | $10.71M+4.9% | $10.21M+5.1% | $9.72M+2.6% | $9.47M+2.3% | $9.26M-1.1% | |
| Sleep And Breathing Health | $128.66M+12.3% | $114.62M+1.8% | $112.56M+1.8% | $110.54M+19.1% | $92.85M+1.1% | |
| R&D by Business | ||||||
| Residential Care Software | $101.73M+1.3% | $100.41M+1.7% | $98.7M+0.8% | $97.96M+0.9% | $97.09M+1.1% | |
| Sleep And Breathing Health | $212.54M+4.5% | $203.37M+2.0% | $199.35M+1.5% | $196.34M+2.4% | $191.82M+0.3% | |
| Goodwill (note 4) by Business | ||||||
| Residential Care Software | $8.63B+0.6% | $8.57B+1.2% | $8.47B+0.5% | $8.43B+0.9% | $8.35B— | |
| Sleep And Breathing Health | $3.55B+4.1% | $3.41B+4.2% | $3.27B+3.6% | $3.16B+4.2% | $3.03B— | |
| Adjustment to fair values of preliminary purchase price allocations by Business | ||||||
| Residential Care Software | $0— | $0— | $0— | $0— | —— | |
| Net revenue by segment by Product | ||||||
| Residential Care Software | $670.9M+1.5% | $661.18M+1.6% | $650.8M+1.5% | $641.44M+2.4% | $626.37M+2.2% | |
| Sleep And Breathing Health | $4.87B+2.7% | $4.74B+2.8% | $4.61B+2.3% | $4.5B+2.5% | $4.4B+1.9% | |
| Cost of sales (exclusive of amortization shown separately below) by Product | ||||||
| Residential Care Software | $201.68M+1.3% | $199.17M+0.9% | $197.48M+1.3% | $194.96M+1.1% | $192.9M+0.2% | |
| Sleep And Breathing Health | $1.89B+0.6% | $1.88B+0.6% | $1.87B+0.3% | $1.86B+0.9% | $1.85B+1.2% | |
| Amortization of Intangible Assets by Product | ||||||
| Residential Care Software | $25.57M+0.7% | $25.4M0.0% | $25.41M-0.2% | $25.47M-1.6% | $25.89M-1.9% | |
| Sleep And Breathing Health | $7.28M+3.4% | $7.04M+2.7% | $6.86M+3.2% | $6.65M+37.2% | $4.84M+2.7% | |
| Net revenue by segment by Geography | ||||||
| Combined Europe, Asia and other markets | $1.65B+3.8% | $1.59B+2.9% | $1.54B+2.3% | $1.51B+3.1% | $1.46B+1.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ResMed break its business down?
- ResMed (RMD) reports net revenue by business across 2 parts — Residential Care Software and Sleep and Breathing Health. Each is extracted from the segment footnotes and tracked over time.
- Where does ResMed's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ResMed's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
